Skip to main content

and
Your search also matched 9 preview-only Content is preview-only when you or your institution have not yet subscribed to it.

By making our abstracts and previews universally accessible we help you purchase only the content that is relevant to you.
results, e.g.

Comprehensive characterization of protein–protein interactions perturbed by disease mutations

Include preview-only content
  1. Article

    Open Access

    The PML1-WDR5 axis regulates H3K4me3 marks and promotes stemness of estrogen receptor-positive breast cancer

    The alternative splicing of PML precursor mRNA gives rise to various PML isoforms, yet their expression profile in breast cancer cells remains uncharted. We discovered that PML1 is the most abundant isoform in al...

    Chun-Peng Pai, Han Wang, Darcie D. Seachrist, Neel Agarwal in Cell Death & Differentiation (2024)

  2. Article

    Open Access

    KLF4 defines the efficacy of the epidermal growth factor receptor inhibitor, erlotinib, in triple-negative breast cancer cells by repressing the EGFR gene

    Triple-negative breast cancer (TNBC) is characterized by high rates of recurrence and poor overall survival. This is due, in part, to a deficiency of targeted therapies, making it essential to identify therape...

    Melyssa S. Roberts, Lindsey J. Anstine, Viviane S. Finke in Breast Cancer Research (2020)

  3. Article

    Open Access

    Follistatin is a metastasis suppressor in a mouse model of HER2-positive breast cancer

    Follistatin (FST) is an intrinsic inhibitor of activin, a member of the transforming growth factor-β superfamily of ligands. The prognostic value of FST and its family members, the follistatin-like (FSTL) prot...

    Darcie D. Seachrist, Steven T. Sizemore, Emhonta Johnson in Breast Cancer Research (2017)

  4. Article

    Open Access

    Mutant p53 dictates the oncogenic activity of c-Abl in triple-negative breast cancers

    We recently established c-Abl as a potent suppressor of triple-negative breast cancer (TNBC) progression through its reactivation of a p53:p21 signaling axis coupled to senescence. Moreover, we observed co-exp...

    Chevaun D Morrison, Jenny C Chang, Ruth A Keri, William P Schiemann in Cell Death & Disease (2017)

  5. Article

    Open Access

    Hotspots of aberrant enhancer activity punctuate the colorectal cancer epigenome

    In addition to mutations in genes, aberrant enhancer element activity at non-coding regions of the genome is a key driver of tumorigenesis. Here, we perform epigenomic enhancer profiling of a cohort of more th...

    Andrea J. Cohen, Alina Saiakhova, Olivia Corradin in Nature Communications (2017)

  6. Article

    Open Access

    Bioengineering of Tobacco Mosaic Virus to Create a Non-Infectious Positive Control for Ebola Diagnostic Assays

    The 2014 Ebola epidemic is the largest to date. There is no cure or treatment for this deadly disease; therefore there is an urgent need to develop new diagnostics to accurately detect Ebola. Current RT-PCR as...

    Patricia Lam, Neetu M. Gulati, Phoebe L. Stewart, Ruth A. Keri in Scientific Reports (2016)

  7. Article

    Open Access

    Intrinsic bias in breast cancer gene expression data sets

    While global breast cancer gene expression data sets have considerable commonality in terms of their data content, the populations that they represent and the data collection methods utilized can be quite disp...

    Jonathan D Mosley, Ruth A Keri in BMC Cancer (2009)

  8. Article

    Open Access

    Cell cycle correlated genes dictate the prognostic power of breast cancer gene lists

    Numerous gene lists or "classifiers" have been derived from global gene expression data that assign breast cancers to good and poor prognosis groups. A remarkable feature of these molecular signatures is that ...

    Jonathan D Mosley, Ruth A Keri in BMC Medical Genomics (2008)